DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,062,359 | +14.8% | 20,405 | +11.1% | 0.12% | +17.8% |
| Q2 2023 | $4,408,922 | +30.6% | 18,370 | +37.1% | 0.10% | +18.8% |
| Q1 2023 | $3,376,960 | -0.2% | 13,399 | +5.1% | 0.08% | -15.8% |
| Q4 2022 | $3,383,444 | +6.4% | 12,748 | +3.6% | 0.10% | -8.2% |
| Q3 2022 | $3,179,000 | +15.4% | 12,307 | +13.3% | 0.11% | +13.4% |
| Q2 2022 | $2,754,000 | -12.5% | 10,864 | +1.2% | 0.10% | -2.0% |
| Q1 2022 | $3,149,000 | -11.2% | 10,738 | -0.4% | 0.10% | -6.6% |
| Q4 2021 | $3,548,000 | +13.3% | 10,783 | +4.8% | 0.11% | 0.0% |
| Q3 2021 | $3,132,000 | +11.9% | 10,288 | -1.4% | 0.11% | +9.3% |
| Q2 2021 | $2,799,000 | +16.0% | 10,431 | -2.7% | 0.10% | +9.0% |
| Q1 2021 | $2,413,000 | +2.0% | 10,716 | +0.6% | 0.09% | -5.3% |
| Q4 2020 | $2,365,000 | -6.7% | 10,647 | -9.5% | 0.09% | -16.1% |
| Q3 2020 | $2,535,000 | -6.5% | 11,768 | -23.2% | 0.11% | -13.8% |
| Q2 2020 | $2,711,000 | +48.9% | 15,327 | +16.5% | 0.13% | +22.6% |
| Q1 2020 | $1,821,000 | +44.2% | 13,155 | +59.8% | 0.11% | +86.0% |
| Q4 2019 | $1,263,000 | +6.4% | 8,233 | +0.1% | 0.06% | +1.8% |
| Q3 2019 | $1,187,000 | +3.2% | 8,222 | +2.1% | 0.06% | +1.8% |
| Q2 2019 | $1,150,000 | +18.1% | 8,051 | +9.1% | 0.06% | +7.8% |
| Q1 2019 | $974,000 | +29.2% | 7,377 | +0.8% | 0.05% | +18.6% |
| Q4 2018 | $754,000 | +2.0% | 7,315 | +7.6% | 0.04% | +10.3% |
| Q3 2018 | $739,000 | +11.0% | 6,797 | +0.7% | 0.04% | +5.4% |
| Q2 2018 | $666,000 | +27.6% | 6,749 | +26.6% | 0.04% | +27.6% |
| Q1 2018 | $522,000 | +1.2% | 5,333 | -4.1% | 0.03% | +3.6% |
| Q4 2017 | $516,000 | +10.0% | 5,561 | +1.6% | 0.03% | +7.7% |
| Q3 2017 | $469,000 | -3.1% | 5,471 | -7.3% | 0.03% | -25.7% |
| Q2 2017 | $484,000 | -6.0% | 5,905 | -1.9% | 0.04% | -5.4% |
| Q1 2017 | $515,000 | +119.1% | 6,017 | +125.7% | 0.04% | +105.6% |
| Q4 2016 | $235,000 | +12.4% | 2,666 | +0.1% | 0.02% | +5.9% |
| Q3 2016 | $209,000 | -54.3% | 2,663 | -40.9% | 0.02% | -56.4% |
| Q2 2016 | $457,000 | +10.4% | 4,506 | +3.1% | 0.04% | +8.3% |
| Q1 2016 | $414,000 | +60.5% | 4,369 | +57.3% | 0.04% | +44.0% |
| Q4 2015 | $258,000 | +13.2% | 2,777 | +4.1% | 0.02% | +4.2% |
| Q3 2015 | $228,000 | +13.4% | 2,668 | +13.4% | 0.02% | +4.3% |
| Q4 2014 | $201,000 | – | 2,352 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |